{
    "nct_id": "NCT04019262",
    "official_title": "Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma: Comparison of Two Established Schedules",
    "inclusion_criteria": "Each patient must meet all of the following inclusion criteria for study enrollment:\n\n* Age ≥18 with ability to provide written informed consent\n* Pathologically confirmed WHO Grade IV Gliobastoma prior receiving radiotherapy\n* Prior radiotherapy to a dose of ≥50Gy\n* No signs of distant metastases\n* Baseline laboratory assessment including CBC and blood chemistry, ANC > or equal 1500, Platelet count greater or equal 100. Liver function tests and creatinine not greater than twice ULN.\n* Patient should not be pregnant. Urine or blood β-HCG within 14 days prior to study start for females who are not atleast one year post-menopausal or who have ot undergone a surgical sterilization procedure\n* A baseline MRI scan of the brain is required to determine how much tumor is present for properly planning patient's radiotherapy.\n* Karnofsky Performance Status (KPS) below 60 or ECOG of 3 or 4\n* Any number or type of prior chemotherapy is allowed (patient may receive concurrent or adjuvant systemic therapy such as cetuximab at the discretion of the treating oncologic team).\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "Patients meeting any of the following exclusion criteria are not eligible for enrollment:\n\n* Evidence of distant metastases on any staging or imaging modality\n* Women who are breast feeding, or have a positive pregnancy test (reproductive age should use effective birth control during study)\n* Any co-morbidity or condition of sufficient severity to limit full compliance with the protocol per assessment by the principal investigator.\n* Karnofsky Performance Status less than 50\n* Prior radiotherapy to involved site in brain.",
    "miscellaneous_criteria": ""
}